For decades, amyloid fibrils have been cast as the static endgame of protein misfolding—once formed, they were thought to persist as inert, terminal aggregates. A new study flips that assumption on its head, revealing that even mature amyloids undergo a slow, spontaneous aging process that fundamentally rewires their architecture, toxicity, and resistance to cellular cleanup. Published in Cell Death Discovery, the work demonstrates that simply letting fully formed fibrils sit for extended periods transforms them into more ordered, less harmful, yet far more stubborn structures—findings that could reshape how we think about protein aggregation diseases from Alzheimer’s to systemic amyloidosis.
Amyloid fibrils are infamous for their cross-β spine, a zipper-like array of β-strands stacked perpendicular to the fibril axis. Once the nucleation barrier is crossed and fibrils elongate, the prevailing view held that the structure was locked in place. Sulatsky, Stepanenko, Kayda, and colleagues challenged this dogma by monitoring mature amyloid assemblies over weeks under near-physiological conditions, using a panel of biophysical probes. They found that, far from being frozen, the fibrils underwent a persistent reorganization, akin to an annealing process that gradually eliminates packing defects.
Using atomic force microscopy, the team observed that aged fibrils became markedly more rigid, with a higher persistence length and a smoother surface topology. Thioflavin T fluorescence, a staple for detecting cross-β structure, increased over time without any addition of new monomers, indicating that the existing β-sheet registry was tightening. Limited proteolysis and chemical denaturation experiments confirmed a substantial gain in stability: aged amyloids were significantly more resistant to proteases like proteinase K and required higher concentrations of guanidine hydrochloride to unwind. X-ray diffraction patterns sharpened, reflecting a more crystalline internal order.
When the researchers probed the biological consequences, the data told a captivating dual story. Freshly prepared mature fibrils displayed the classic, moderate cytotoxicity when added to cultured neuronal and epithelial cells, triggering membrane damage and oxidative stress. However, those same fibrils, after aging for several weeks, lost much of their cell-killing potency. The response suggests that the structural maturation masks or buries the solvent-exposed hydrophobic patches and transiently exposed toxic surfaces that are responsible for membrane perturbation. In essence, time transforms a pathogenic threat into a relatively inert, cemented deposit.
Yet this loss of toxicity came with a dark trade-off. The investigators examined how macrophages and proteolytic clearance systems handled the aged aggregates. In phagocytosis assays, aged fibrils were internalized far less efficiently, and they proved remarkably resistant to degradation inside the lysosomal compartment. Even purified proteasomal and lysosomal extracts struggled to break down the time-seasoned amyloids. This dual shift—lower immediate harm but enhanced persistence—paints a nuanced picture: the body might tolerate an aged plaque for years, but it becomes virtually impossible to clear, allowing it to accumulate silently.
Mechanistically, the aging phenomenon appears to be driven by a slow relaxation of the fibril’s internal energy landscape. After the rapid growth phase, the polypeptide chains are kinetically trapped in a metastable configuration riddled with minor structural defects—misaligned side chains, water-filled cavities, or strained hydrogen bonds. Over time, thermal fluctuations allow these defects to anneal away, strengthening the backbone hydrogen-bond network and optimizing side-chain packing. This molecular spackling raises the activation barrier for unfolding and proteolytic attack, locking the fibril into a deeply stable, glass-like state.
The implications for neurodegenerative diseases are profound. Amyloid plaques in Alzheimer’s disease can exist for years, and this study suggests they are not static tombstones but evolving entities. The progressive loss of toxicity in aged fibrils might explain the poor correlation between total amyloid burden and cognitive decline, while the enhanced resistance to clearance could account for the stubborn, chronic nature of deposits. Even more intriguingly, if aging reduces cytotoxicity, therapies designed to accelerate this maturation might sequester toxic oligomers into inert, stable fibrils—a strategy already explored with certain small-molecule stabilizers.
Beyond the clinic, the concept of spontaneous aging may extend to functional amyloids in bacteria, fungi, and even mammalian hormone storage granules, where tuning lifetime and clearance is critical. The work also underscores a methodological lesson: the age of a fibril preparation matters enormously, and comparing samples of different history can confound reproducibility. As the team behind this discovery urges, time is not just a passive variable but an active, transformative force in amyloid biology that demands to be studied on its own terms.
Subject of Research: Spontaneous aging of mature amyloid fibrils and its impact on structural stability, cytotoxicity, and susceptibility to biological clearance.
Article Title: Spontaneous aging of mature amyloids alters structural stability, cytotoxicity, and susceptibility to biological clearance.
Article References:
Sulatsky, M.I., Stepanenko, O.V., Kayda, A.A. et al. Spontaneous aging of mature amyloids alters structural stability, cytotoxicity, and susceptibility to biological clearance.
Cell Death Discov. (2026). https://doi.org/10.1038/s41420-026-03245-1
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41420-026-03245-1
Keywords: amyloid, aging, fibril stability, cytotoxicity, biological clearance, protein aggregation, cross-beta structure, neurodegeneration, structural maturation, annealing, clearance resistance
